Vitamin D and Chronic Kidney Disease
Abstract
Keywords
Full Text:
PDFReferences
Scott MG, Gronowski AM, Reid IR, Holick MF, Thadhani R,
Phinney K. Vitamin D: The more we know, the less we know.
Clin Chem 2015;61:462‑5.
Kostoglou‑Athanassiou I, Athanassiou P, Lyraki A, Raftakis I,
Antoniadis C. Vitamin D and rheumatoid arthritis. Ther Adv
Endocrinol Metab 2012;3:181‑7.
Kostoglou‑Athanassiou I, Athanassiou P, Gkountouvas A,
Kaldrymides P. Vitamin D and glycemic control in diabetes
mellitus type 2. Ther Adv Endocrinol Metab 2013;4:122‑8.
Zhou R, Wang M, Huang H, Li W, Hu Y, Wu T. Lower vitamin
D status is associated with an increased risk of ischemic
stroke: A systematic review and meta‑analysis. Nutrients
;10:pii:E277.
Jean G, Souberbielle JC, Chazot C. Vitamin D in chronic kidney
disease and dialysis patients. Nutrients 2017;9:pii:E328.
Caravaca‑Fontán F, Gonzales‑Candia B, Luna E, Caravaca F.
Relative importance of the determinants of serum levels of
‑hydroxy vitamin D in patients with chronic kidney disease.
Nefrologia 2016;36:510‑6.
Alem AM, Sherrard DJ, Gillen DL, Weiss NS, Beresford SA,
Heckbert SR, et al. Increased risk of hip fracture
among patients with end‑stage renal disease. Kidney Int
;58:396‑9.
Barreto Silva MI, Cavalieri VV, Lemos CC, Klein MR,
Bregman R. Body adiposity predictors of vitamin D status
in nondialyzed patients with chronic kidney disease:
A cross‑sectional analysis in a tropical climate city. Nutrition
;33:240‑7.
Pereira‑Santos M, Costa PR, Assis AM, Santos CA, Santos DB.
Obesity and vitamin D deficiency: A systematic review and
meta‑analysis. Obes Rev 2015;16:341‑9.
Bataille S, Landrier JF, Astier J, Giaime P, Sampol J, Sichez H,
et al. The “dose‑effect” relationship between 25‑hydroxyvitamin
d and muscle strength in hemodialysis patients favors a normal
threshold of 30 ng/ml for plasma 25‑hydroxyvitamin D. J Ren
Nutr 2016;26:45‑52.